Mikiko Takikita
Overview
Explore the profile of Mikiko Takikita including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
501
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cho H, Noh K, Chung J, Takikita M, Chung E, Kim B, et al.
PLoS One
. 2014 Jun;
9(6):e98712.
PMID: 24905095
Synaptonemal complex protein 3 (SCP3), a member of Cor1 family, is up-regulated in various cancer cells; however, its oncogenic potential and clinical significance has not yet been characterized. In the...
2.
Kitano H, Chung J, Ylaya K, Conway C, Takikita M, Fukuoka J, et al.
J Histochem Cytochem
. 2014 Feb;
62(5):335-46.
PMID: 24487999
Activation of numerous pathways has been documented in non-small cell lung cancer (NSCLC). Epidermal growth factor receptor (EGFR) has emerged as a common therapeutic target. The mitogen-activated protein kinase (MAPK)...
3.
Uchiyama K, Nakanishi G, Fujimoto N, Takikita M, Tanaka T
Eur J Dermatol
. 2013 Sep;
23(4):557-8.
PMID: 24001792
No abstract available.
4.
Chung J, Kitano H, Takikita M, Cho H, Noh K, Kim T, et al.
Hum Pathol
. 2012 Oct;
44(4):472-9.
PMID: 23069255
Synaptonemal complex protein 3 is a marker for cell transformation that has prognostic significance in various cancers. However, the prognostic significance of synaptonemal complex protein 3 has not been studied...
5.
Lenz P, Pfeiffer R, Baris D, Schned A, Takikita M, Poscablo M, et al.
Cancer Epidemiol Biomarkers Prev
. 2012 Jul;
21(9):1555-64.
PMID: 22761304
Background: Cell-cycle proteins are important predictive markers in urothelial carcinoma but may also exhibit exposure-specific heterogeneity. Methods: Tumor tissue from 491 bladder cancer cases enrolled in the Maine and Vermont...
6.
Levine P, Portera C, Hoffman H, Yang S, Takikita M, Duong Q, et al.
Clin Breast Cancer
. 2012 Jun;
12(4):232-9.
PMID: 22694825
Background: Inflammatory breast cancer (IBC) is an aggressive form of breast cancer that on presentation resembles locally advanced breast cancer (LABC). This study identified molecular features of IBC and LABC...
7.
Yoshida K, Miyahira Y, Ishida M, Iwai M, Kagotani A, Arita N, et al.
Diagn Cytopathol
. 2012 Jan;
41(4):354-9.
PMID: 22282082
Herpes simplex virus (HSV) infection is usually observed in the oral cavity and external genitals, and HSV peritonitis is extremely rare. Herein, we report a case of type II HSV...
8.
Takikita M, Xie R, Chung J, Cho H, Ylaya K, Hong S, et al.
J Transl Med
. 2011 Aug;
9:126.
PMID: 21801427
Background: Head and neck squamous cell carcinoma (HNSCC) still remains a lethal malignancy benefiting from the identification of the new target for early detection and/or development of new therapeutic regimens...
9.
Takikita M, Hu N, Shou J, Giffen C, Wang Q, Wang C, et al.
Anticancer Res
. 2011 Apr;
31(3):945-52.
PMID: 21498718
Background: Several studies have suggested that fascin, cytokeratin 14 and cytokeratin 4 may have significant roles as biomarkers for the progression and survival of esophageal squamous cell carcinoma (ESCC). Materials...
10.
Su H, Hu N, Yang H, Wang C, Takikita M, Wang Q, et al.
Clin Cancer Res
. 2011 Mar;
17(9):2955-66.
PMID: 21385931
Purpose: Esophageal squamous cell carcinoma (ESCC) is an aggressive tumor with poor prognosis. Understanding molecular changes in ESCC will enable identification of molecular subtypes and provide potential targets for early...